GlassScriptPhysician profile
Brian John Ulmer
NPI 1184657918
$28,696.69
in general payments reported to CMS, 2019-2025
17 companies · $669 in 2025
The $669 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $7,292 · 2021: $2,363 · 2022: $25.51 · 2023: $150 · 2024: $215 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $26,186.24 | 2019-2021 | |
| Roche Diagnostics Corporation | $1,030.10 | 2019 | |
| Tandem Diabetes Care, INC. | $243.66 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $240.49 | 2023-2024 | |
| Roche Diabetes Care, INC. | $195.95 | 2019 | |
| Cequr Corporation | $138.94 | 2023-2025 | Cequr Simplicity |
| Corcept Therapeutics | $127.99 | 2024-2025 | Korlym |
| Sequel Med Tech, LLC | $123.59 | 2025 | Twiist |
| Medtronic Minimed, INC. | $115.70 | 2019 | |
| Abbott Laboratories | $55.17 | 2019-2024 | Freestyle Libre 3 |
| Averitas Pharma INC. | $51.53 | 2025 | Qutenza |
| Mannkind Corporation | $50.00 | 2021 | |
| Insulet Corporation | $43.50 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $25.87 | 2025 | |
| Medtronic, INC. | $25.49 | 2025 | Minimed 780g |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $24.53 | 2025 | Unithroid |
| Xeris Pharmaceuticals, INC. | $17.94 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ulmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.